Revolutionizing Rare Disease Treatment: Introducing Soligenix's Breakthrough HyBryte™
Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company specializing in developing and commercializing products to treat rare diseases with unmet medical needs. The Company's primary focus is on its Specialized BioTherapeutics business segment, which is responsible for the development of HyBryte™, a novel photodynamic therapy that uses safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL). The Company has successfully completed a Phase 3 study for HyBryte™ and is now negotiating a confirmatory Phase 3 pivotal study design with the US Food & Drug Administration, while also evaluating/pursuing potential HyBryte™ marketing approval ex-U.S. with the successfully completed Phase 3 study. Visit https://www.redchip.com/stocks/SNGX/ to learn more.
Transcription:
Soligenix opens enrollment of expanded clinical trial of HyBryte in cutaneous T-cell lymphoma, building on the successful Phase 3 study. Discussions with FDA on design of a confirmatory Phase 3 study of HyBryte are underway. Learn more at SNGXinfo.com.
-
0:22
RedChip
11 months agoHyBryte™ by Soligenix: Transforming Cutaneous T-Cell Lymphoma Treatment
10 -
3:15
RedChip
1 year agoSoligenix: Advancing Rare Disease Treatments and Fighting Emerging Diseases
6 -
3:35
Atomic Analyzer
6 months agoCRISPR Milestone: UK Approves the Revolutionary Treatment for Genetic Diseases
571 -
2:43
Just the News
1 year agoFDA considers gene therapy to treat rare muscle disease
1.86K1 -
6:02
biologix
1 year agoNew Hope for People with Treatment-resistant Infections
16 -
1:13
Waking the World up
3 months agoShemane Nugent with David Schmidt - mRNA Post Jab Study – Mutation in WBC's - “Horns and a Tail”
1.69K -
1:25
Sandr001
1 year agoDerma ProGenix Advanced Anti-Aging Skin Care Serum - Derma Progenix Review
32 -
1:03:03
Health Biz and Politics
3 months agoChronic Resistance to Healing - Even Lyme - Finds Promise in the Biofield
157 -
2:04
Real Truth Real News
1 year ago💥 HUGE! Hydroxychloroquine Allows Viruses to Attack Cancer Cells While Leaving Healthy Cells, Healthy....
7.31K20 -
2:33
BrioMedical
6 months agoPersonalized Peptides for the Treatment of Cancer | Brio-Medical Cancer Clinic in Scottsdale, AZ
29